Measurable residual disease monitoring in <scp>AML</scp>: Prospects for therapeutic decision‐making and new drug development

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27482

Keywords:

Abstract:

Source: